Pharma

Apr 17 2018

About SwAPP – SwAPP, Swiss Association of Pharmaceutical Professionals, pharmaceutical association.#Pharmaceutical #association

About SwAPP SwAPP was founded in 1995 as the professional association for qualified specialists working in one of the many fields of pharmaceutical medicine and drug development. SwAPP members come from pharmaceutical companies, contract research organisations, health care institutions, biotech companies, health authorities and ethics committees. SwAPP welcomes members with an academic background, for example in life sciences, biology, pharmaceutics or a similar field, and physicians, as well as non-academic health professionals. SwAPP promotes a Life Long Learning Program with SwAPP diplomas and continuous professional training. SwAPP is growing continuously and has today more than 300 members. 80% of the …

Apr 4 2018

English, Japan Pharmaceutical Manufacturers Association(JPMA), generic pharmaceutical association.#Generic #pharmaceutical #association

generic pharmaceutical association An introduction of JPMA, from our philosophy to our organizational framework and details of our specific activities. JPMA’s policies and guidelines. To expedite the launch of innovative medicines for the peoples in asia The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): JPMA activities and events related to ICH. Shared Dreams of Better Health Across Borders, Across Time Reports and data sheets concerning the pharmaceutical industry and market. Overview of Japanese regulations

Mar 14 2018

Pharmaceutical manufacturers association, pharmaceutical manufacturers association.#Pharmaceutical #manufacturers #association

ARPharM ЖИВОТОСПАСЯВАЩИ ТЕРАПИИ МОЖЕ ДА НЕ ДОСТИГНАТ ДО БЪЛГАРСКИТЕ ПАЦЕНТИ ПРЕЗ 2018 Г. ЗАРАДИ МОРАТРОРИУМ ВЪРХУ ЗАПЛАЩАНЕТО ИМ ОТ НЗОК 27.10.2017 г. гр. София. Много нови лекарствени терапии, които пациентите в повечето европейски държави получават, може да останат недостъпни за българските пациенти и през 2018 г., предупредиха от Асоциацията на научноизследователските фармацевтични производители в България (ARPharM). Причината е мораториум върху заплащането им от НЗОК през 2018 г., приет от Надзорния съвет на НЗОК, който предстои да бъде разгледан от Парламента. Оказва се, че поради тази забрана широко прокламираното увеличение на средствата за здраве с 400 милиона лв. няма да доведе …

Mar 14 2018

Home Page, PhRMA, pharmaceutical manufacturers association.#Pharmaceutical #manufacturers #association

pharmaceutical manufacturers association PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource …

Feb 14 2018

Home Page, PhRMA, pharmaceutical association.#Pharmaceutical #association

pharmaceutical association PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource Library, …

Jan 22 2018

International Research-Based Pharmaceutical Manufacturers Association, pharmaceutical manufacturers association.#Pharmaceutical #manufacturers #association

pharmaceutical manufacturers association Established in July 1992, IRPMA consists of 40+ research-based pharmaceutical manufacturers from Europe, Japan, and the U.S. with a presence in Taiwan. The purposes of the Association are to promote the development of research-based pharmaceuticals, enhance the ethical standards of the pharmaceutical industry and strengthen its contribution to the advancement of public health. The members of IRPMA have been continuously bringing new drugs into Taiwan, and are dedicated to improving the health care quality and living standard of the people in Taiwan through clinical development and professional promotion. Contributions made by IRPMA Members Actively introduce new drugs …

Jan 9 2018

English, Japan Pharmaceutical Manufacturers Association(JPMA), pharmaceutical association.#Pharmaceutical #association

pharmaceutical association An introduction of JPMA, from our philosophy to our organizational framework and details of our specific activities. JPMA’s policies and guidelines. To expedite the launch of innovative medicines for the peoples in asia The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): JPMA activities and events related to ICH. Shared Dreams of Better Health Across Borders, Across Time Reports and data sheets concerning the pharmaceutical industry and market. Overview of Japanese regulations

Jan 9 2018

Home Page, PhRMA, pharmaceutical association.#Pharmaceutical #association

pharmaceutical association PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource Library, …

Jan 9 2018

About SwAPP – SwAPP, Swiss Association of Pharmaceutical Professionals, pharmaceutical association.#Pharmaceutical #association

About SwAPP SwAPP was founded in 1995 as the professional association for qualified specialists working in one of the many fields of pharmaceutical medicine and drug development. SwAPP members come from pharmaceutical companies, contract research organisations, health care institutions, biotech companies, health authorities and ethics committees. SwAPP welcomes members with an academic background, for example in life sciences, biology, pharmaceutics or a similar field, and physicians, as well as non-academic health professionals. SwAPP promotes a Life Long Learning Program with SwAPP diplomas and continuous professional training. SwAPP is growing continuously and has today more than 300 members. 80% of the …

Dec 26 2017

Pharmaceutical manufacturers association #barr #pharma

#pharmaceutical manufacturers association # Welcome to the Website of the Korea Pharmaceutical Manufacturers Association The Korea Pharmaceutical Manufacturers Association, since its foundation in 1945, along with pharmaceutical companies has been committed to improve healthcare for all mankind and develop pharmaceutical industry. With about 190 member companies, KPMA expanded R D investments since the implementation of Drug Substance Patent Law in 1987 to place Korea in the world’s 10th country to commercialize new molecular entities in 2003. Up until the end of 2008, 14 new molecular entities products were developed in the country, with 45 projects from 29 companies undergoing clinical …